Background: The HEART score and North American Chest Pain Rule (NACPR) are decision rules designed to identify acute chest pain patients for early discharge without stress testing or cardiac imaging. This study compares the clinical utility of these decision rules combined with serial troponin determinations. Methods and results: A secondary analysis was conducted of 1005 participants in the Myeloperoxidase In the Diagnosis of Acute coronary syndromes Study (MIDAS). MIDAS is a prospective observational cohort of Emergency Department (ED) patients enrolled from 18 US sites with symptoms suggestive of acute coronary syndrome (ACS). The ability to identify participants for early discharge and the sensitivity for ACS at 30 days were compared among an unstructured assessment, NACPR, and HEART score, each combined with troponin measures at 0 and 3 h. ACS, defined as cardiac death, acute myocardial infarction, or unstable angina, occurred in 22% of the cohort. The unstructured assessment identified 13.5% (95% CI 11.5-16%) of participants for early discharge with 98% (95% CI 95-99%) sensitivity for ACS. The NACPR identified 4.4% (95% CI 3-6%) for early discharge with 100% (95% CI 98-100%) sensitivity for ACS. The HEART score identified 20% (95% CI 18-23%) for early discharge with 99% (95% CI 97-100%) sensitivity for ACS. The HEART score had a net reclassification improvement of 10% (95% CI 8-12%) versus unstructured assessment and 19% (95% CI 17-21%) versus NACPR. Conclusions: The HEART score with 0 and 3 hour serial troponin measures identifies a substantial number of patients for early discharge while maintaining high sensitivity for ACS.
Introduction
Although patients frequently present with symptoms of suspected acute coronary syndrome (ACS), risk stratification remains challenging and inefficient. Although the Thrombosis in Myocardial Infarction (TIMI) risk score and Global Registry of Acute Coronary Events (GRACE) score are recommended to aid risk stratification, they are not sensitive enough to avoid objective testing or inpatient care [1] [2] [3] [4] . Emergency Department (ED) patients with low-risk TIMI and GRACE scores have ACS rates above the acceptable miss rate of 1% [3, 5] . More sensitive rules have been reported, but they identify fewer than 20% of acute chest pain patients for early discharge [6, 7] .
The HEART score and North American Chest Pain Rule (NACPR) are recently developed decision rules designed to identify ED patients with symptoms suggestive of ACS for early discharge without objective cardiac testing (stress testing or cardiac imaging). However, both require further validation before prospective implementation [7, 8] . In addition, there is little evidence comparing the clinical utility of these decision rules to each other or to an unstructured clinical evaluation (a clinical assessment based on physician gestalt without the use of a clinical decision rule).
Decision rules attempting to identify patients for early discharge based on a single troponin measurement have had varying success, highlighting the importance of serial troponin measurements to increase sensitivity [9, 10] . Recently, we reported that adding a second troponin measurement to the HEART score improved sensitivity for major adverse cardiac events from 58% to 100% in a low-risk cohort designated for observation unit care [9] . Therefore, the objective of this study was to determine the ability of three risk stratification strategies -an unstructured clinician assessment, NACPR, and HEART score, each combined with serial troponin measures -to identify patients for early discharge while maintaining an acceptable ACS miss rate (below 1%).
Methods

Study design
A secondary analysis was conducted of patients prospectively enrolled in the Myeloperoxidase In the Diagnosis of Acute coronary syndromes Study (MIDAS), clinical trial number NCT00415948. Participants were enrolled from May 2006 to September 2007, and all gave informed consent at the time of study entry. Details of the MIDAS trial have been previously described [11] . The MIDAS protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the Institutional Review Board of each participating institution.
Participants
Participants were enrolled from 18 US tertiary care center EDs. Eligibility criteria required subjects to be at least 18 years old, with symptoms of suspected ACS, starting within 6 h of presentation and lasting at least 30 min, in whom the physician planned objective cardiac testing. Acceptable objective cardiac testing was defined as: invasive coronary angiography, computed tomography coronary angiography, or stress testing with electrocardiography, nuclear imaging, cardiac magnetic resonance imaging, or echocardiography. Patients were excluded if they were unable or unwilling to consent to serial blood draws and a 30-day follow-up phone interview. All patients received medical care consistent with local practice, including local biomarker ordering and interpretation, which was unaffected by enrollment in MIDAS.
Risk stratification strategies
The unstructured assessment consisted of a 5-point Likert scale of ACS probability completed by the physician at subject enrollment. Low-risk was defined by an ACS probability score of 1 and negative troponin results at 0 and 3 h. High risk was defined by a Likert score of ≥2, or a troponin level ≥0.05 ng/ml at 0 or 3 h. Timepoints of 0 and 3 h were used because contemporary troponin assays identify most patients with acute myocardial infarction within 3 h of ED arrival [10, 12, 13] .
While all five elements of the NACPR were collected in MIDAS (Fig. 1 ), adaptations were required to calculate the NACPR for this study. In MIDAS, ECG interpretation was determined by the site investigator as "consistent with ACS", "not consistent with ACS", or "unchanged from prior." The NACPR ECG variable "acute ischemic ECG changes" was defined from MIDAS as an investigator determination of an ECG "consistent with ACS." A "history consistent with ACS" was defined as an ACS probability Likert score of ≥2. In MIDAS, known coronary disease was determined by the site investigator through record review or patient self-report. As in the NACPR derivation study, we used age ≥50 years as a cut-point [7] . We considered, patients with any high risk category in the NACPR, including a troponin level ≥0.05 ng/ml at 0 or 3 h, as high risk. Our serial troponin measurements differed from the NACPR derivation study, which used 0 and 6 hour timepoints. A sensitivity analysis was performed by adding a 6-hour serial troponin measure [7] .
Elements of the HEART score were also collected in MIDAS (Fig. 1 ), but again adaptations were required. To determine the history component, a MIDAS ACS probability Likert score of 1 was defined as slightly suspicious (0 points for the HEART score), 2 as moderately suspicious (1 point), and ≥3 as highly suspicious (2 points). An ECG interpretation "consistent with ACS" by a MIDAS investigator was given 2 points for the HEART score ECG component, while a MIDAS interpretation of "unchanged from prior" or "not consistent with ACS" was given 0 points. Risk factors included in the HEART score were available from MIDAS data, except for family history. HEART scores were calculated for each study participant. Low-risk was defined as a HEART score of 0 to 3 with negative 0 and 3 hour troponin measures; high risk was defined as a HEART score of ≥4, or any positive troponin result [8, 14] . Risk stratification definitions described above were determined a priori and scores were determined blinded to patient outcomes.
Venous blood samples were collected, as part of MIDAS, in ethylene diamine tetraacetic acid and the plasma stored at −80°C within 1 h of collection. Troponin measures for the risk stratification strategies were performed centrally using the Triage Cardio3 TnI point of care platform (Alere, Waltham, MA) [15] . The reference value for this assay was determined using banked plasma samples from healthy controls. The 99th percentile TnI reference value for the Cardio3 TnI assay is b0.05 ng/ml, and has a coefficient of variation of 16.7% at this cut-point [16] . A negative troponin result was defined as b0.05 ng/ml, and positive as ≥0.05 ng/ml. Local investigators were blinded to these troponin results and they were not used to determine clinical outcomes.
Outcomes
Results from clinical care, record review, and follow-up (e.g. ECG, local biomarker, objective cardiac testing, or cardiac catheterization results) were used by site investigators to determine gold standard clinical outcomes. Our primary outcome was rate of ACS within 30 days of presentation, defined as the composite of cardiac death, acute myocardial infarction (AMI), and unstable angina (UA). The definition of ACS and its components were based on the standardized reporting guidelines for studies evaluating risk stratification of Emergency Department patients with potential acute coronary syndromes [5] . In MIDAS, AMI was determined by site-adjudicated diagnosis performed locally by study investigators based on cardiac diagnostics and troponins performed as routine care. The number of troponins obtained for the site-adjudicated diagnosis was based on the local standard of care. Central biomarker testing was not used by site investigators in outcome adjudication. The protocol-specified definition of AMI was a typical rise and gradual fall of troponin with at least one of the following: ischemic symptoms, development of pathological ECG Q waves, ECG changes indicative of ischemia, or coronary revascularization. An a priori decision was made to include all patients with an adjudicated diagnosis of AMI in this analysis regardless of type: ST-segment elevation AMI (STEMI) or non-ST-segment elevation AMI (NSTEMI). Although most patients with a STEMI do not provide a diagnostic or disposition dilemma to emergency physicians, we decided to include patients with STEMIs, because some present atypically or without ST-elevation on the initial ECG.
UA was defined by ischemia confirmed by ECG ST-segment changes with recurrent symptoms or a troponin elevation that did not meet AMI criteria and required either ≥70% coronary stenosis on coronary angiography, or inducible ischemia with stress testing if cardiac catheterization was not performed. This definition of UA is compliant with the standardized reporting guidelines [5] . Determination of the primary outcome was performed locally by hospital record review and structured telephone interviews occurring at 30 days following the index visit ±2 days, consistent with standardized reporting guidelines for ED ACS risk stratification studies [5] . Patients were identified for early discharge if they were low-risk by a decision rule and had negative troponins at 0 and 3 h. This identified a population for each clinical decision rule that could have been discharged from the ED or Observation Unit without objective cardiac testing.
Statistical methods
Univariate logistic regression was used to model the relationship between risk stratification strategy and ACS at 30 days. The percentage of patients identified for early discharge and sensitivity for ACS was calculated for each strategy. The sensitivity of serial troponin results at 0 and 3 h used alone (without a decision rule) was calculated to determine the incremental value of a clinical decision rule when added to serial troponin testing. C-statistics were used to evaluate and compare the clinical utility of each strategy using the method of Hanley and McNeil [17, 18] .
Net reclassification improvement (NRI) was calculated for each pairwise comparison of risk stratification strategies. Results from each risk stratification strategy were used to classify patients as high or low-risk. The NRI was calculated based on each rule's ability to increase the proportion of high-risk patients experiencing ACS and decrease the proportion of low-risk patients experiencing ACS [18, 19] .
Sensitivity analyses were performed to assess the impact of changing the definition of a low-risk ACS probability Likert score, missing data, and adding a serial 6-hour troponin measure. In the first sensitivity analysis, low-risk for the unstructured assessment and the history component of the NACPR were changed from a Likert score of 1 to a score of ≤2. A slightly suspicious HEART score history (0 points) was modified (from a Likert score of 1) to a score of ≤2, a moderately suspicious history (1 point) was changed to a score of 3, and a highly suspicious history (2 points) was changed to a score of ≥4. The impact of missing data was assessed using simple random selection imputation based on variable frequencies in the complete data set. For example, assessment for diabetes was incomplete in 33 patients and the rate of diabetes in the complete data set was 27%, therefore diabetes was randomly assigned to 9 of the 33 patients with missing data. Family history was imputed with simple random selection using a 30% positive family history rate, due to similar rates in the literature [8] . The impact of combining serial troponins at 0, 3, and 6 h with each decision rule was assessed by classifying patients as high risk if they had a positive troponin at any serial measurement or were high risk by a decision rule. Statistical analysis was performed using SAS 9.2 (Cary, North Carolina). The unstructured assessment identified 13.5% (95% CI 11.5-16%) of patients for early discharge without objective cardiac testing. In comparison, the NACPR identified 4% (95% CI 3-6%) and the HEART score identified 20% (95% CI 18-23%) for early discharge. All three risk stratification strategies had high sensitivities with point estimates missing less than 1% of ACS events. The 95% confidence interval for missed ACS rate remained below 1% for the NACPR and HEART score strategies, but exceeded 1% for the unstructured assessment. Fig. 1 . The North American Chest Pain Rule (NACPR) and the HEART score. NACPR: patients are considered low-risk if they have none of the high risk criteria. The HEART score: low-risk = 0-3, high risk = 4 or greater. Risk factors include currently treated diabetes mellitus, current or recent (b90 days) smoker, diagnosed and/or treated hypertension, diagnosed hypercholesterolemia, family history of coronary artery disease, obesity (body mass index ≥30), or a history of significant atherosclerosis (coronary revascularization, myocardial infarction, stroke, or peripheral arterial disease). ECG = electrocardiogram, ACS = acute coronary syndrome. The sensitivity for the unstructured assessment was 98% (95% CI 95-99%) compared to 100% (95% CI 98-100%) for the NACPR and 99% (95% CI 97-100%) for the HEART score. The sensitivity of serial troponins used alone, without a decision rule, was only 56% (95% CI 49-62%). The initial troponin was positive in 34% (75/222) of the patients with 30 day ACS events. The 3 hour troponin picked up an additional 49 patients for a total of 56% (124/222) of ACS patients. The addition of a serial 3 hour troponin to the unstructured assessment and HEART score resulted in the identification of 1 patient with ACS that would have been missed using the decision rules with a single troponin measurement. See Table 2 Table 3 .
Results
From
Comparing the HEART score strategy to the unstructured or NACPR strategies resulted in a net reclassification improvement (NRI) of 10% (95% CI 8-12%) and 19% (95% CI 17-21%) respectively. The NACPR compared to the unstructured assessment resulted in an NRI of − 9% (95% CI − 10, − 8%). A summary of c-statistics and net reclassification improvement for the various risk stratification strategies is presented in Table 4 . A summary of missed events is presented in Table 5 and Fig. 3 .
The sensitivity analysis for changing the low-risk ACS probability definition from a Likert score of 1 to ≤2 increased the number of patients identified for early discharge by the NACPR (8.5%, 95% CI 7-10%) and HEART score (30%, 95% CI 27-33%) while decreasing sensitivity (99.6%, 95% CI 97.5-100% and 98%, 95% CI 95-99%, respectively). The sensitivity analysis for missing data demonstrated that absent data had little impact on the performance of the risk stratification strategies (Appendix 1). Adding a 6-hour serial troponin measure to the risk stratification strategies resulted in the identification of one additional ACS event at 30 days for the unstructured assessments and the HEART score (Appendix 2).
Discussion
This analysis suggests that an unstructured assessment, NACPR, and HEART score, combined with 0 and 3 hour troponin measurements, can identify ED patients with acute chest pain for early discharge while retaining an acceptable ACS miss rate (below1%). These findings have added impact as these rules were applied to a cohort identified by their physicians as requiring objective cardiac testing. In fact, nearly 90% of this cohort were either admitted or received objective cardiac testing prior to discharge. While all risk stratification strategies would have resulted in a 30 day adverse event rate of less than 1%, the The number of patients with and without ACS identified as high and low-risk by the risk stratification strategies, the percentage identified for early discharge, sensitivity, specificity, negative likelihood ratio, and area under the curve. n = number, −LR = negative likelihood ratio, AUC = area under the curve (c-statistic), NACPR = North American Chest Pain Rule.
unstructured assessment had an upper bound of the 95% confidence interval exceeding 1%, suggesting that the HEART score and NACPR may provide greater safety.
Combining clinical decision rules with serial troponin measurement appears to be a key to successful risk stratification. Prior attempts to define a very low-risk cohort based on a single troponin measurement have had varying success highlighting the importance of serial measurements to maximize sensitivity [9, 20] . Recently the ASia-Pacific Evaluation of Chest pain Trial (ASPECT) demonstrated that with serial cardiac biomarkers, a very low adverse event rate can be achieved [6] . Similarly, we reported that adding a second troponin measurement to the HEART score resulted in a 0% miss rate in a low-risk cohort designated for observation unit care [9] . Findings from this MIDAS analysis are consistent with these previous studies. Furthermore, this analysis demonstrates the value of adding a clinical decision rule to serial troponins. Serial troponins at 0 and 3 h had a sensitivity of 56% and would have missed 98 patients with ACS at 30 days. The addition of a decision rule resulted in an absolute increase in sensitivity of 42-44% for 30 day ACS.
High sensitivities for ED chest pain risk stratification strategies often come at the expense of identifying patients for early discharge. Maximizing sensitivity results in many false-positive cases (patients identified as high risk without an event at 30 days) and low numbers of true negatives (patients identified as low-risk without an event at 30 days). For example, ASPECT reported sensitivity above 99%, but identified fewer than 10% of patients for early discharge without objective cardiac testing [6] . The derivation study of the NACPR reported a sensitivity of 100% and identified 18% for early discharge [7] . The results are less impressive when considering that NACPR and ASPECT enrolled patients at all risk levels, including those at very-low-risk for ACS, who would have been identified for discharge with or without the use of a decision rule. In contrast, MIDAS eligibility criteria required patients identified by their providers as needing objective cardiac testing. As a result, most very-low-risk patients were not included (22% event rate). Previous ED risk stratification studies have reported rates of 5-18% [6] [7] [8] 20, 21] .
We identified fewer patients for early discharge by the NACPR rule than in its derivation publication. This difference may be explained by inclusion of very-low-risk patients in the earlier study, or differences in primary outcome measures. The NACPR derivation study's primary outcome was major adverse cardiac events (MACE) at 30 days; a composite endpoint of death, AMI, and coronary revascularization. In this analysis, the primary outcome was ACS at 30 days, defined by cardiac death, AMI, or UA. Including UA as an outcome reflects the concept that failure to identify those at high risk for future events is a lost opportunity to initiate therapy [22] .
In this analysis, the HEART score identified a much larger group of patients for early discharge than the NACPR or unstructured assessment. The ability of the HEART score to identify 20% of patients for early discharge would reduce costs, radiation exposure, and decrease false positive and non-diagnostic testing [1] . In addition, the HEART score combined with two troponin assays has now demonstrated a miss rate of 0% and 0.2% in two separate analyses with over 2000 patients [9] . Considering these findings with results of the HEART score derivation and validations performed in Europe using a single troponin assessment, the HEART score appears sufficiently safe and effective to warrant prospective validation.
Study limitations
This cohort consists of ED patients from tertiary referral centers with a planned objective cardiac evaluation, and represents a higher risk group than an undifferentiated chest pain population. However, patients at lower risk than these probably would have even fewer adverse events, suggesting that our protocol would safely identify more ED patients for early discharge, as found in a previous analysis [9] . The NACPR and HEART score were not tested exactly as originally derived due to limitations of available data; however, our sensitivity analyses suggest that this had little impact on our findings. Limited data also prevented inclusion of TIMI and ADAPT in this analysis. The central troponin assay used in the clinical decision rules was not a high sensitivity assay. Nonetheless, clinical decision rules used with serial troponin measures achieved high sensitivity for detection of ACS at 30 days. MIDAS was conducted before widespread adoption of high-sensitivity troponin assays; thus, occurrence of AMI in MIDAS is based on conventional troponin assay results. Smaller troponin elevations probably were not identified as AMI. However, because nearly the entire cohort received objective cardiac testing, many of these patients likely were diagnosed with UA and still considered to have ACS. The performance of these decision rules combined with the highest sensitivity troponin assays would likely maintain a high sensitivity for ACS, but the impact on the identification of patients for early discharge is unknown. Finally, our primary outcome measure, ACS during index visit or within 30 days, was adjudicated at each site, so inconsistencies may have occurred. Variability was minimized by using objective definitions of outcomes and site monitoring visits. Performance of local adjudication of cardiovascular events was comparable to central adjudication in an earlier report [23] . Furthermore, local adjudication to determine clinical outcomes at multiple sites using local data such as ECGs, biomarkers, and objective cardiac testing adds external validity to the results.
Conclusions
The HEART score combined with serial troponins identified a substantial number of patients for early discharge with a low missed ACS rate. Use of a structured clinical ACS risk assessment combined with two troponin results is highly sensitive for the detection of ACS. The HEART score plus serial troponins could improve efficiency and quality of chest pain care in the ED. A prospective study of the implementation of the HEART score and serial troponins is warranted.
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UA
Characteristics of the 5 patients with missed ACS by the unstructured assessment and the 2 patients with missed ACS by the HEART score. ACS = acute coronary syndrome, CAD = coronary artery disease, CABG = coronary artery bypass graft, NSTEMI = Non ST-elevation Myocardial Infarction, AMI = acute myocardial infarction, PCI = percutaneous coronary intervention, CABG = coronary artery bypass graft, UA = unstable angina, STEMI = ST-elevation myocardial infarction, ECG = electrocardiogram. Fig. 3 . Number of ACS events at 30 days. AMI, unstable angina, and cardiac deaths, missed by each risk stratification strategy. ACS = acute coronary syndrome, AMI = acute myocardial infarction. A comparison of each risk stratification strategy using net reclassification improvement and c-statistic change. n = number, NRI = net reclassification improvement, ACS = acute coronary syndrome, NACPR = North American Chest Pain Rule.
